Active — Not RecruitingNot Applicable

Predictors and Clinical Outcomes of Patients With Coronary Heart Disease Co-morbid Depression Post Percutaneous Coronary Intervention

China2,600 participantsStarted 2019-08-28

Plain-language summary

A prospective, multicenter, registered cohort study to observe the incidence of 1-year major adverse cardiac events in patients with coronary heart disease co-morbid depression treated with percutaneous coronary intervention and to clarify the predictors of 1-year major adverse cardiac events post PCI among these patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Provision of informed consent prior to any study specific procedures;
✓. Men and women 18 years or older；
✓. Diagnosed CHD needed to and can be treated with PCI according to the guidelines of ACC/AHA；
✓. Willingness to participate in the follow-up study for at least 1 year.

Exclusion criteria

✕. Inability to provide written informed consent;
✕. Diagnosed mental illness or medical history (including schizophrenia, bipolar disorder, severe dementia or Lifetime alcohol or substance abuse);
✕. Tendency of suicide;
✕. Pregnant or lactating women;
✕. Any physical or intellectual inability or disability that may affect completion of self-assessment tools, study protocol and follow-up requirements;
✕. Any other reasons that investigators based on professional judgments that would place the patient at increased risk.
✕. Patient with STEMI within 24-hour from the onset of chest pain to admission.

What they're measuring

Number of Participants with Major Adverse Events

Timeframe: 36-month

Trial details

NCT IDNCT03852082

SponsorNanjing First Hospital, Nanjing Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-30

View on ClinicalTrials.gov More Coronary Heart Disease trials